Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Common Equity (2017 - 2020)

enVVeno Medical has reported Common Equity over the past 4 years, most recently at $4.8 million for Q3 2020.

  • Quarterly results put Common Equity at $4.8 million for Q3 2020, up 55.48% from a year ago — trailing twelve months through Sep 2020 was $4.8 million (up 55.48% YoY), and the annual figure for FY2019 was $989940.0, down 51.39%.
  • Common Equity for Q3 2020 was $4.8 million at enVVeno Medical, up from $369446.0 in the prior quarter.
  • Over the last five years, Common Equity for NVNO hit a ceiling of $4.8 million in Q3 2020 and a floor of -$15.7 million in Q1 2018.
  • Median Common Equity over the past 4 years was $2.5 million (2018), compared with a mean of $4939.2.
  • Biggest five-year swings in Common Equity: soared 118.3% in 2018 and later plummeted 100.51% in 2020.
  • enVVeno Medical's Common Equity stood at -$11.1 million in 2017, then soared by 118.3% to $2.0 million in 2018, then tumbled by 51.39% to $989940.0 in 2019, then skyrocketed by 384.37% to $4.8 million in 2020.
  • The last three reported values for Common Equity were $4.8 million (Q3 2020), $369446.0 (Q2 2020), and -$14623.0 (Q1 2020) per Business Quant data.